References
- MASAKI T at at.: Cardiovascular Drug Rev. (1990) 4:373–385.
- DOHERTY AM et al.: Ann. Rep. Med. Chem. (1992) 27:79–88.
- LERMAN A et al.: Mayo Cltn. Proc. (1990) 65:1441–1455.
- RANDALL MD et at.: Phannac. Ther. (1991) 50:73–93.
- DOHERTY AM: J. Med. Chem. (1992) 35:1493.
- DOHERTY AM at al.: J. Med. Chem. (1992) 35:1493–1508.
- YANAGISAWA M at at.: Nature (1988) 332:411–415.
- YANAGISAWA M et al.: Proc. Natl. Acad. Sct. USA (1988) 85:6964–6967.
- YANAGISAWA M at al.: Biochem. Pharmacol. (1989) 38:1877–1883.
- SOGABE K at al.:J. Pharmacol. Exp. Res. (1993) 3:1040–1046.
- CODY WL et al.: J. Med. Chem. (1992) 35:3033.
- FUJIMOTO M et al.: FEES Lett. (1992) 305:41.
- CLOZEL M et at.: Nature (1993) 365:759.
- URADE Y et al.: FERS Lett (1992) 311:12.
- TAKAI M at at.: Biochem. Biophys. Res. Commun. (1992) 184:953.
- ARAMORI I at at.: Mol. Pharmacol. (1993) 43:127–131.
- CARDELL LO et at.: Br. J. Pharmacol. (1993) 108:448–452.
- ISHIKAWA K etal.: EP-0460679-A2 (1991).
- CODY W etal.: Mol. Chem. Res. (1993) 3:154–162.
- BANYU PHARM CO, US5114918.
- FUJISAWA PHARM CO, EP457195–A2.
- SHIONOGI SEIYAKU, EP526642–A1.
- FUJISAWA PHARM CO, EP405421–A2.
- TAICEDA, JP-4134048.
- a. HOFFMANN-LA ROCHE, EP510526–A1
- b. HOFFMANN-LA ROCHE, EP526708–A1.
- SMITHKLINE BEECHAM CORP, W093/080799.
- BANYU PHARM CO, EP460679–A2.